Mo1912 – Vedolizumab in Elderly Patients with Inflammatory Bowel Disease is Associated with Improved Disease Outcomes and Low Rates of Serious Infection: A Single Center Real World Experience

Authors :: Elizabeth A. Scoville
Rochelle Wong
Robin Dalal
Baldeep S. Pabla
David A. Schwartz
Sara N. Horst
Dawn B. Beaulieu
Amir H. Kashani
Source :: Gastroenterology. 156:S-883
Publication Year :: 2019
Publisher :: Elsevier BV, 2019.

Subjects :: medicine.medical_specialty
Hepatology
Disease outcome
business.industry
Gastroenterology
Serious infection
Single Center
medicine.disease
Inflammatory bowel disease
Vedolizumab
Internal medicine
medicine
business
medicine.drug

Tools